Wearable Injectors Market to See Strong Growth and Business Opportunities | P&S Intelligence

The surging aging population and increasing prevalence of chronic diseases are two of the key factors driving the growth of the wearable injectors market. In 2015, the market generated revenue of $2,162.1 million, and it is predicted to attain a size of over $13,000.0 million by 2024, progressing at a CAGR of 23.0% during the forecast period (2016-2024). A wearable injector is a device used for delivering a huge amount of a drug over an extended time period. It delivers heavy amounts of subcutaneous drugs to patients, even if the patient is ambulatory.

Based on technology, the wearable injectors market is classified into electronic, mechanical, and others. Among these, during the 2012-2015 period, the electronic injector classification led the market in terms of revenue, and it is expected to continue leading it during the forecast period. An electronic wearable injector consists of a cartridge filed with the drug and a drug delivery part, which is operated electronically. These wearable injectors offer benefits such as automated delivery, advanced safety, and smooth handling; therefore, these are widely used by patients who are looking for convenient dosing.

Request to Get the Sample Pages at:
https://www.psmarketresearch.com/market-analysis/wearable-injectors-market/report-sample

Thus, the increasing usage of electronic wearable injectors is predicted to boost the wearable injectors market growth during 2016-2024. Surging life expectancy and drop in birth rates are two of the prime reasons behind the surging geriatric population. According to the United Nations Department of Economic and Social Affairs, the number of people aged 60 or above is predicted to surge by 56.0%, i.e. from 901 million in 2015 to 1.4 billion by 2030. It further stated that by 2050, the population is expected to reach around 2.1 billion.

Access Detailed Report Summary:
https://www.psmarketresearch.com/market-analysis/wearable-injectors-market

Owing to their longer recovery time, low immunity level and susceptibility to chronic diseases, such as diabetes, cancer, cardiovascular diseases, and neurological disorders, the elderly need extensive care. As per the World Health Organization, in 2014, 422 million people suffered from diabetes. In 2014, the highest incidence of diabetes, of around 13.7%, was found in the Eastern Mediterranean region, followed by Southeast Asia (8.6%). Furthermore, as per the Centers for Disease Control and Prevention, in 2012, in the U.S., nearly 117 million people were suffering from one or more chronic health problems.

Thus, the increasing population of the elderly and rising prevalence of chronic diseases are heavily contributing to the growth of the market.

About P&S Intelligence
P&S Intelligence is a provider of market research and consulting services catering to the market information needs of burgeoning industries across the world. Providing the plinth of market intelligence, P&S as an enterprising research and consulting company, believes in providing thorough landscape analyses on the ever-changing market scenario, to empower companies to make informed decisions and base their business strategies with astuteness.

Contact:
P&S Intelligence
Toll-free: +1-888-778-7886 (USA/Canada)
International: +1-347-960-6455
Email: enquiry@psmarketresearch.com
Web: https://www.psmarketresearch.com

This release was published on openPR.